Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
5.10
-0.16 (-3.04%)
At close: Mar 28, 2025, 4:00 PM
5.12
+0.02 (0.41%)
After-hours: Mar 28, 2025, 7:51 PM EDT

Monte Rosa Therapeutics Statistics

Total Valuation

GLUE has a market cap or net worth of $313.70 million. The enterprise value is -$15.73 million.

Market Cap 313.70M
Enterprise Value -15.73M

Important Dates

The last earnings date was Thursday, March 20, 2025, before market open.

Earnings Date Mar 20, 2025
Ex-Dividend Date n/a

Share Statistics

GLUE has 61.51 million shares outstanding. The number of shares has increased by 43.80% in one year.

Current Share Class 61.51M
Shares Outstanding 61.51M
Shares Change (YoY) +43.80%
Shares Change (QoQ) +0.13%
Owned by Insiders (%) 0.96%
Owned by Institutions (%) 60.40%
Float 33.92M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.98
Forward PS 10.93
PB Ratio 1.41
P/TBV Ratio 1.41
P/FCF Ratio 8.25
P/OCF Ratio 7.47
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.19.

Current Ratio 2.40
Quick Ratio 2.37
Debt / Equity 0.19
Debt / EBITDA n/a
Debt / FCF 1.12
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -36.15% and return on invested capital (ROIC) is -20.65%.

Return on Equity (ROE) -36.15%
Return on Assets (ROA) -13.66%
Return on Invested Capital (ROIC) -20.65%
Return on Capital Employed (ROCE) -28.78%
Revenue Per Employee $564,343
Profits Per Employee -$542,537
Employee Count 134
Asset Turnover 0.20
Inventory Turnover n/a

Taxes

In the past 12 months, GLUE has paid $2.57 million in taxes.

Income Tax 2.57M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -27.56% in the last 52 weeks. The beta is 1.50, so GLUE's price volatility has been higher than the market average.

Beta (5Y) 1.50
52-Week Price Change -27.56%
50-Day Moving Average 6.13
200-Day Moving Average 6.08
Relative Strength Index (RSI) 35.58
Average Volume (20 Days) 833,715

Short Selling Information

The latest short interest is 7.03 million, so 11.44% of the outstanding shares have been sold short.

Short Interest 7.03M
Short Previous Month 8.04M
Short % of Shares Out 11.44%
Short % of Float 20.74%
Short Ratio (days to cover) 13.40

Income Statement

In the last 12 months, GLUE had revenue of $75.62 million and -$72.70 million in losses. Loss per share was -$0.98.

Revenue 75.62M
Gross Profit -37.24M
Operating Income -81.11M
Pretax Income -129.93M
Net Income -72.70M
EBITDA -72.99M
EBIT -81.11M
Loss Per Share -$0.98
Full Income Statement

Balance Sheet

The company has $372.15 million in cash and $42.72 million in debt, giving a net cash position of $329.43 million or $5.36 per share.

Cash & Cash Equivalents 372.15M
Total Debt 42.72M
Net Cash 329.43M
Net Cash Per Share $5.36
Equity (Book Value) 222.94M
Book Value Per Share 3.62
Working Capital 220.49M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $42.00 million and capital expenditures -$3.99 million, giving a free cash flow of $38.01 million.

Operating Cash Flow 42.00M
Capital Expenditures -3.99M
Free Cash Flow 38.01M
FCF Per Share $0.62
Full Cash Flow Statement

Margins

Gross margin is -49.25%, with operating and profit margins of -107.26% and -96.14%.

Gross Margin -49.25%
Operating Margin -107.26%
Pretax Margin -92.74%
Profit Margin -96.14%
EBITDA Margin -96.52%
EBIT Margin -107.26%
FCF Margin 50.26%

Dividends & Yields

GLUE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -43.80%
Shareholder Yield n/a
Earnings Yield -23.18%
FCF Yield 12.12%

Analyst Forecast

The average price target for GLUE is $14.33, which is 180.98% higher than the current price. The consensus rating is "Buy".

Price Target $14.33
Price Target Difference 180.98%
Analyst Consensus Buy
Analyst Count 3
Revenue Growth Forecast (5Y) 1.09%
EPS Growth Forecast (5Y) 12.89%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

GLUE has an Altman Z-Score of -0.3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.3
Piotroski F-Score 2